Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Dialysate sodium and short-term blood pressure variability in patients with intradialytic hypertension: a randomized crossover study

Abstract

Increased blood pressure (BP) variability (BPV) is associated with high cardiovascular risk in hemodialysis. Patients with intradialytic hypertension (IDH) also exhibit an increased cardiovascular risk compared to hemodialysis patients without this condition. The impact of non-pharmacological BP-lowering interventions on BPV in this population remains unknown. This analysis evaluated the effect of low (137mEq/L) compared to standard (140mEq/L) dialysate sodium concentration on short-term BPV in patients with IDH. In a randomized cross-over manner, 29 IDH patients underwent 4 hemodialysis sessions with low (137mEq/L) followed by 4 sessions with standard (140mEq/L) dialysate sodium or vice versa. 48 h ambulatory BP measurement was performed from the start of the 4th session on each dialysate sodium. BPV indices during the 48 h, 24 h, day-time and night-time periods were calculated. Mean 48 h BP was 5.3/2.6 mmHg lower with low compared to standard dialysate sodium concentration, (p = 0.005/p = 0.007 respectively). All 48 h systolic BPV indices examined showed non-significant differences between low and standard dialysate sodium (SBP-SD: 16.99 ± 5.39 vs. 16.98 ± 4.33 mmHg, p = 0.982; SBP-wSD: 15.93 ± 5.02 vs. 16.12 ± 4.16 mmHg, p = 0.769; SBP-ARV: 11.99 ± 3.67 vs. 11.45 ± 3.35 mmHg, p = 0.392; SBP-CV: 12.36 ± 3.65 vs. 11.92 ± 3.18%, p = 0.302, with low vs. standard dialysate sodium, respectively). Diastolic BPV indices were numerically, but not statistically, lower with low dialysate sodium. Overall, significant differences were observed in some comparisons with a trend for lower BPV during day-time 2 and higher BVP during night-time 2 with low dialysate sodium. In conclusion, low dialysate sodium concentration does not affect BPV levels in patients with IDH. Future research should explore alternative interventions to reduce BP and BPV in this high-risk population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Differences between low and standard dialysate sodium in 48-h SBP and DBP variability indices.

Similar content being viewed by others

Data availability

Access to trial data can be made available to researchers upon reasonable request to the corresponding author.

References

  1. United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. (2022).

  2. Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro C, et al. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). J Hypertens. 2017;35:657–76.

    Article  CAS  PubMed  Google Scholar 

  3. Karpetas A, Sarafidis PA, Georgianos PI, Protogerou A, Vakianis P, Koutroumpas G, et al. Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis. Clin J Am Soc Nephrol. 2015;10:630–8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Karpetas A, Loutradis C, Bikos A, Tzanis G, Koutroumpas G, Lazaridis AA, et al. Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients. J Hypertens. 2017;35:2517–26.

    Article  CAS  PubMed  Google Scholar 

  5. Georgianos PI, Sarafidis PA, Zoccali C. Intradialysis Hypertension in End-Stage Renal Disease Patients: Clinical Epidemiology, Pathogenesis, and Treatment. Hypertension. 2015;66:456–63.

    Article  CAS  PubMed  Google Scholar 

  6. Iatridi F, Theodorakopoulou MP, Papagianni A, Sarafidis P. Intradialytic hypertension: epidemiology and pathophysiology of a silent killer. Hypertens Res. 2022;45:1713–25.

    Article  PubMed  Google Scholar 

  7. Inrig JK, Patel UD, Toto RD, Szczech LA. Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis. 2009;54:881–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Park J, Rhee CM, Sim JJ, Kim Y-L, Ricks J, Streja E, et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int. 2013;84:795–802.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Inrig JK, Oddone EZ, Hasselblad V, Gillespie B, Patel UD, Reddan D, et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int. 2007;71:454–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, et al. Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles. Hypertension. 2016;67:1102–10.

    Article  CAS  PubMed  Google Scholar 

  11. Parati G, Bilo G, Kollias A, Pengo M, Ochoa JE, Castiglioni P, et al. Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper . J Hypertens. 2023;41:527–44.

    CAS  PubMed  Google Scholar 

  12. Sarafidis PA, Ruilope LM, Loutradis C, Gorostidi M, de la Sierra A, de la Cruz JJ, et al. Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients. J Hypertens. 2018;36:1076–85.

    Article  CAS  PubMed  Google Scholar 

  13. Alexandrou ME, Loutradis C, Schoina M, Tzanis G, Dimitriadis C, Sachpekidis V, et al. Ambulatory blood pressure profile and blood pressure variability in peritoneal dialysis compared with hemodialysis and chronic kidney disease patients. Hypertens Res. 2020;43:903–13.

    Article  PubMed  Google Scholar 

  14. Flythe JE, Inrig JK, Shafi T, Chang TI, Cape K, Dinesh K, et al. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis. 2013;61:966–74.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Chang TI, Flythe JE, Brunelli SM, Muntner P, Greene T, Cheung AK, et al. Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. J Hum Hypertens. 2014;28:18–24.

    Article  CAS  PubMed  Google Scholar 

  16. Sarafidis PA, Loutradis C, Karpetas A, Tzanis G, Bikos A, Raptis V, et al. The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients. Nephrol Dial Transplant. 2019;34:515–23.

    Article  PubMed  Google Scholar 

  17. Bikos A, Angeloudi E, Memmos E, Loutradis C, Karpetas A, Ginikopoulou E, et al. A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension. Am J Nephrol. 2018;48:295–305.

    Article  PubMed  Google Scholar 

  18. Loutradis C, Bikos A, Raptis V, Afkou Z, Tzanis G, Pyrgidis N, et al. Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension. Hypertens Res. 2019;42:1001–10.

    Article  CAS  PubMed  Google Scholar 

  19. Inrig JK, Molina C, D’Silva K, Kim C, Van Buren P, Allen JD, et al. Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis: a randomized crossover study. Am J Kidney Dis. 2015;65:464–73.

    Article  CAS  PubMed  Google Scholar 

  20. Robberechts T, Allamani M, Galloo X, Wissing KM, Van Der Niepen P. Individualized Isonatremic and Hyponatremic Dialysate Improves Blood Pressure in Patients with Intradialytic Hypertension: A Prospective Cross-Over Study with 24-h Ambulatory Blood Pressure Monitoring. Open Journal of Nephrology. 2020;10:144–57.

    Article  CAS  Google Scholar 

  21. Nair SV, Balasubramanian K, Ramasamy A, Thamizhselvam H, Gharia S, Periasamy S Effect of low dialysate sodium in the management of intradialytic hypertension in maintenance hemodialysis patients: A single-center Indian experience. Hemodial Int Published Online First: 18 March 2021. https://doi.org/10.1111/hdi.12921

  22. Iatridi F, Malandris K, Ekart R, Xagas E, Karpetas A, Theodorakopoulou MP, et al. Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study. Nephrol Dial Transplant. 2024:gfae104. https://doi.org/10.1093/ndt/gfae104. Epub ahead of print.

  23. Wei W, Tölle M, Zidek W, van der Giet M. Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit. 2010;15:225–8.

    Article  PubMed  Google Scholar 

  24. Loutradis C, Sarafidis PA, Theodorakopoulou M, Ekart R, Alexandrou ME, Pyrgidis N, et al. Lung Ultrasound-Guided Dry-Weight Reduction in Hemodialysis Patients Does Not Affect Short-Term Blood Pressure Variability. Am J Hypertens. 2019;32:786–95.

    Article  CAS  PubMed  Google Scholar 

  25. Nongnuch A, Campbell N, Stern E, El-Kateb S, Fuentes L, Davenport A. Increased postdialysis systolic blood pressure is associated with extracellular overhydration in hemodialysis outpatients. Kidney Int. 2015;87:452–7.

    Article  PubMed  Google Scholar 

  26. Van Buren PN, Zhou Y, Neyra JA, Xiao G, Vongpatanasin W, Inrig J, et al. Extracellular Volume Overload and Increased Vasoconstriction in Patients With Recurrent Intradialytic Hypertension. Kidney Blood Press Res. 2016;41:802–14.

    Article  PubMed  Google Scholar 

  27. Song JH, Park GH, Lee SY, Lee SW, Lee SW, Kim M-J. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol. 2005;16:237–46.

    Article  PubMed  Google Scholar 

  28. Oberleithner H, Riethmüller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA. 2007;104:16281–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Rubinger D, Backenroth R, Sapoznikov D. Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS One. 2012;7:e36943.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int. 2004;65:1568–76.

    Article  PubMed  Google Scholar 

  31. Mitsuhashi H, Tamura K, Yamauchi J, Ozawa M, Yanagi M, Dejima T, et al. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. Atherosclerosis. 2009;207:186–90.

    Article  CAS  PubMed  Google Scholar 

  32. Chen Z, Sun F, Shen Y, Ma L, Liu J, Zhou Y. Impact of Dialysate Sodium Concentration Lowering on Home Blood Pressure Variability in Hemodialysis Patients. Ther Apher Dial. 2019;23:153–9.

    Article  CAS  PubMed  Google Scholar 

  33. Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33:1058–66.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Research idea and study design: Fotini Iatridi, Pantelis Sarafidis; data acquisition: Fotini Iatridi, Efstathios Xagas, Robert Ekart, Antonios Karpetas, Ioanna Revela, Marieta Theodorakopoulou, Eleni Karkamani, Nikolaos Devrikis; data analysis/interpretation: Fotini Iatridi, Pantelis Sarafidis; statistical analysis: Fotini Iatridi; manuscript drafting: Fotini Iatridi, Pantelis Sarafidis; supervision or mentorship: Aikaterini Papagianni, Pantelis Sarafidis.

Corresponding author

Correspondence to Fotini Iatridi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

The study protocol was approved by the Ethics Committee of the School of Medicine, Aristotle University of Thessaloniki (Approval Number 4555).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iatridi, F., Ekart, R., Xagas, E. et al. Dialysate sodium and short-term blood pressure variability in patients with intradialytic hypertension: a randomized crossover study. J Hum Hypertens (2024). https://doi.org/10.1038/s41371-024-00947-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41371-024-00947-w

Search

Quick links